{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:55:14Z","timestamp":1793145314123,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170345"],"award-info":[{"award-number":["RP170345"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"CDMRP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-23-1148519-01-IBCD"],"award-info":[{"award-number":["RSG-23-1148519-01-IBCD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA054174"],"award-info":[{"award-number":["CA054174"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["T32GM113896"],"award-info":[{"award-number":["T32GM113896"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008636","name":"Institute for Integration of Medicine and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006772","name":"Max and Minnie Tomerlin Voelcker Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neo.2025.101187","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:04:18Z","timestamp":1748376258000},"page":"101187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["CD56 on intratumoral NK cells: orchestrating NK cell-mediated anti-tumor effects in bladder cancer"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2919-7164","authenticated-orcid":false,"given":"Zaineb","family":"Hassouneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-9338","authenticated-orcid":false,"given":"Onika D.V.","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5852-6484","authenticated-orcid":false,"given":"Niannian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4178-2324","authenticated-orcid":false,"given":"Natalia","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Svatek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101187_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051181","article-title":"Immunotherapy in bladder cancer: current methods and future perspectives","volume":"12","author":"Wo\u0142\u0105cewicz","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101187_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236016","article-title":"Checkpoint inhibition in bladder cancer: clinical expectations, current evidence, and proposal of future strategies based on a tumor-specific immunobiological approach","volume":"13","author":"Mancini","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101187_bib0003","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101187_bib0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","article-title":"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma","volume":"89","author":"Boivin","year":"2009","journal-title":"Lab. Investig."},{"key":"10.1016\/j.neo.2025.101187_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0007","doi-asserted-by":"crossref","first-page":"36492","DOI":"10.18632\/oncotarget.26362","article-title":"Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101187_bib0008","article-title":"KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer","author":"Mukherjee","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.neo.2025.101187_bib0009","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1083\/jcb.149.6.1249","article-title":"The tyrosine kinase PYK-2\/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing","volume":"149","author":"Sancho","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neo.2025.101187_bib0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57346","article-title":"CD56 regulates human NK cell cytotoxicity through Pyk2","volume":"9","author":"Gunesch","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neo.2025.101187_bib0011","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1038\/s41598-019-45377-8","article-title":"CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse","volume":"9","author":"Taouk","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101187_bib0012","doi-asserted-by":"crossref","first-page":"36492","DOI":"10.18632\/oncotarget.26362","article-title":"Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101187_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12171","article-title":"Human NK cell development requires CD56-mediated motility and formation of the developmental synapse","volume":"7","author":"Mace","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101187_bib0014","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1111\/febs.16880","article-title":"CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners","volume":"290","author":"Sohngen","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.neo.2025.101187_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1074-7613(03)00032-3","article-title":"Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition","volume":"18","author":"Goping","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2025.101187_bib0016","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.192.10.1403","article-title":"Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation","volume":"192","author":"Sutton","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neo.2025.101187_bib0017","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.3389\/fimmu.2018.03173","article-title":"Inhibitory receptor crosslinking quantitatively dampens calcium flux induced by activating receptor triggering in NK cells","volume":"9","author":"Ganesan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0018","doi-asserted-by":"crossref","first-page":"ar64","DOI":"10.1091\/mbc.E23-12-0463","article-title":"CD56\/NCAM mediates cell migration of human NK cells by promoting integrin-mediated adhesion turnover","volume":"35","author":"Martinez","year":"2024","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neo.2025.101187_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030357","article-title":"New perspectives in the medical treatment of non-muscle-invasive bladder cancer: immune checkpoint inhibitors and beyond","volume":"11","author":"Audisio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neo.2025.101187_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fonc.2020.00175","article-title":"Modifying the non-muscle invasive bladder cancer immune microenvironment for optimal therapeutic response","volume":"10","author":"Annels","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2025.101187_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/BLC-220109","article-title":"NK cell-targeted immunotherapies in bladder cancer: beyond checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.neo.2025.101187_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184712","article-title":"Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy","volume":"13","author":"Leblond","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101187_bib0023","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1172\/JCI89717","article-title":"ILC2-modulated T cell\u2013to-MDSC balance is associated with bladder cancer recurrence","volume":"127","author":"Chevalier","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neo.2025.101187_bib0024","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1172\/JCI90387","article-title":"CD56bright NK cells exhibit potent antitumor responses following IL-15 priming","volume":"127","author":"Wagner","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neo.2025.101187_bib0025","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0026","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/s41598-017-06238-4","article-title":"CD56 is a pathogen recognition receptor on human natural killer cells","volume":"7","author":"Ziegler","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101187_bib0027","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200210158","article-title":"Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis","volume":"160","author":"Metkar","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neo.2025.101187_bib0028","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.neo.2025.101187_bib0029","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1074\/jbc.272.13.8310","article-title":"NCAM140 interacts with the focal adhesion kinase p125(fak) and the SRC-related tyrosine kinase p59(fyn)","volume":"272","author":"Beggs","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2025.101187_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0031","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: a 'tag game' between NK cells and malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.neo.2025.101187_bib0032","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-05-2520","article-title":"Proteolytic release of soluble UL16-binding protein 2 from tumor cells","volume":"66","author":"Waldhauer","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101187_bib0033","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101187_bib0034","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","article-title":"NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)","volume":"121","author":"Romee","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101187_bib0035","doi-asserted-by":"crossref","first-page":"ra96","DOI":"10.1126\/scisignal.2005629","article-title":"A signaling network stimulated by beta2 integrin promotes the polarization of lytic granules in cytotoxic cells","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neo.2025.101187_bib0036","article-title":"Novel role of Src in priming Pyk2 phosphorylation","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neo.2025.101187_bib0037","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexmp.2014.01.002","article-title":"Production and expression of RANTES (CCL5) by human disc cells and modulation by IL-1-beta and TNF-alpha in 3D culture","volume":"96","author":"Gruber","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.neo.2025.101187_bib0038","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.omto.2021.10.001","article-title":"The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy","volume":"23","author":"Fabian","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.neo.2025.101187_bib0039","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.2147\/CMAR.S250071","article-title":"CD56 expression is associated with biological behavior of pancreatic neuroendocrine neoplasms","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.neo.2025.101187_bib0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cncr.11458","article-title":"CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy","volume":"99","author":"Farinola","year":"2003","journal-title":"Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:32:48Z","timestamp":1762547568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"alternative-id":["S1476558625000661"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101187","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD56 on intratumoral NK cells: orchestrating NK cell-mediated anti-tumor effects in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101187"}}